|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 253.80 EUR | -0.24% |
|
-3.13% | +6.37% |
| 07-03 | Berenberg Updates Price Target, Estimates for UCB on Recent Pipeline Deals | MT |
| 06-25 | US prices for new drugs fell in 2025 as fewer costly gene therapies were launched | RE |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
Compared values
| Sector | Change | 5-day change | YTD change | 1-year change | 5-year change | Capi. | ST | MT | LT | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| UCB | Biopharmaceuticals | -0.24% | -3.13% | +6.37% | +49.38% | +185.17% | 55.3B |  | | |
- Stock Market
- Stocks
- UCB Stock
- Charts UCB
- Comparison Chart
Choose MarketScreener Select your edition
All financial news and data tailored to specific country editions
